Gapping down In reaction to disappointing earnings/guidance: BNNY -2%, UNFI -1.5%, I -1.5%, OXM -1.3%.
Select EU financial related names showing weakness: NBG -3.4%, UBS -1.9%, ING -1.8%, SAN -1.3%, DB -1%, BCS -0.9%.
Other news: OREX -15.9% (receives three month extension of FDA NB32 review), PVA -5% (announced proposed private offering of $250 mln of depositary shares representing convertible preferred stock), RCPT -3.7% (filed $150 mln shelf ), CTIC -3.2% (still checking), HLT -2.7% (files for 90 mln share common stock offering by selling shareholders), SN -2.5% (announces offering of 5 mln shares of common stock & private offering of $700 mln in Senior Notes), IDRA -2.3% (still checking), EXC -2.1% (plans to commence concurrent registered offerings of 50 mln shares of its common stock in connection with forward sales agreements and 20 mln equity units), STAY -2% (announced offering of 21 mln paired shares by selling stockholders), BAC -1.1% (settlement negotiations with DoJ hit a roadblock, according to reports), CHL -1.1% (Moody's said China Mobile's investment in True Corp is credit negative), PRAN -1% (seeing continued strength (+20% over past two days)), LLY -0.9% (announces top-line results of Phase III Hepatocellular Carcinoma trial; did not meet its primary endpoint; overall survival favored the CYRAMZA arm but was not statistically significant), DAL -0.8% (German carrier Lufthansa issued profit warning).
Analyst comments: DCIX -1.5% (downgraded to Underweight from Equal weight at Barclay), BA -1.2% (downgraded to Sector Perform at RBC Capital Mkts), BEAV -0.7% (downgraded to Hold from Buy at Jefferies, downgraded to Hold from Buy at Canaccord Genuity), DDD -0.6% (downgraded at Gabelli).